Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 17, 2013 - Issue 2
Submit an article Journal homepage
301
Views
10
CrossRef citations to date
0
Altmetric
Brief Report

Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): implications for psychiatry services in the general hospital

Debajeet ChoudhuriDepartment of Liaison Psychiatry, South London and Maudsley NHS Foundation Trust, London, UK
,
Sean CrossDepartment of Liaison Psychiatry, South London and Maudsley NHS Foundation Trust, London, UK
,
Paul I. DarganDepartment of Clinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust and King's Health Partners, London, UK;King's College London, St Thomas’ Hospital, London, UK
,
David M. WoodDepartment of Clinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust and King's Health Partners, London, UK;King's College London, St Thomas’ Hospital, London, UK
&
Gopinath RanjithDepartment of Liaison Psychiatry, South London and Maudsley NHS Foundation Trust, London, UKCorrespondence[email protected]
Pages 154-156 | Received 23 Sep 2012, Accepted 25 Feb 2013, Published online: 12 Apr 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Filipa Raposo Pereira, Minni T. B. McMaster, YvonD. A. T. de Vries, Wim van den Brink & Guido A. van Wingen. (2020) Demographic and Clinical Characteristics of Regular GHB-Users with and without GHB-Induced Comas. Substance Use & Misuse 55:13, pages 2148-2155.
Read now

Articles from other publishers (9)

B.A.G. Dijkstra, H. Beurmanjer, A.E. Goudriaan, A.F.A. Schellekens & E.A.G. Joosten. (2021) Unity in diversity: A systematic review on the GHB using population. International Journal of Drug Policy 94, pages 103230.
Crossref
Christopher N. Floyd, David M. Wood & Paul I. Dargan. (2017) Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability. European Journal of Clinical Pharmacology 74:3, pages 349-356.
Crossref
Òscar Miró, Miguel Galicia, Paul Dargan, Alison M. Dines, Isabelle Giraudon, Fridtjof Heyerdahl, Knut E. Hovda, Christopher Yates, David M. Wood, Evangelia Liakoni, Matthias Liechti, Gesche Jürgens, Carsten Boe Pedersen, Niall O’Connor, Gerard Markey, Adrian Moughty, Christopher Lee, Patrick O’Donohoe, Jacek Sein Anand, Jordi Puiguriguer, Catalina Homar, Florian Eyer, Odd Martin Vallersnes, Per Sverre Persett, Lucie Chevillard, Bruno Mégarbane, Raido Paasma, W. Stephen Waring, Kristiina Põld, Christian Rabe & Piotr Maciej Kabata. (2017) Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse. Toxicology Letters 277, pages 84-91.
Crossref
Rama M. Kamal, Martijn S. van Noorden, Wim Wannet, Harmen Beurmanjer, Boukje A. G. Dijkstra & Arnt Schellekens. (2016) Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs 31:1, pages 51-64.
Crossref
David M. Wood. 2017. Critical Care Toxicology. Critical Care Toxicology 1555 1586 .
Anne Lingford-Hughes, Yash Patel, Owen Bowden-Jones, Mike J. Crawford, Paul I. Dargan, Fabiana Gordon, Steve Parrott, Tim Weaver & David M. Wood. (2016) Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial. Trials 17:1.
Crossref
David M. Wood. 2016. Critical Care Toxicology. Critical Care Toxicology 1 32 .
Jenny Bearn & Matthew O'Brien. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse 205 233 .
Jan van Amsterdam, Tibor Brunt, Ed Pennings & Wim van den Brink. (2014) Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB. Regulatory Toxicology and Pharmacology 70:2, pages 507-513.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.